Clinical Trials Logo

Unresectable Osteosarcoma clinical trials

View clinical trials related to Unresectable Osteosarcoma.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02243605 Active, not recruiting - Clinical trials for Recurrent Osteosarcoma

Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma

Start date: December 19, 2014
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well cabozantinib s-malate works in treating patients with osteosarcoma or Ewing sarcoma that has grown or returned (come back) after a period of improvement. Cabozantinib s-malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and may also prevent the growth of new blood vessels that tumors need to grow.